John L. Erb's most recent trade in Nuwellis Inc was a trade of 115,329 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuwellis Inc | John L. Erb | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 115,329 | 115,329 | - | - | Incentive Stock Option (right to buy) | |
| Nuwellis Inc | John L. Erb | Director, CEO and President, Ten Percent Owner | 09 Jun 2025 | 1,092,500 | 1,092,500 (5%) | 5% | 0.1 | 65,550 | Common Stock | |
| Nuwellis Inc | John L. Erb | Director, CEO and President, Ten Percent Owner | 09 Jun 2025 | 7,522 | 1,100,022 (5%) | 0% | 0.1 | 451 | Common Stock | |
| Nuwellis Inc | John L. Erb | Director, CEO and President, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Jun 2025 | 100 | 0 | - | - | Series F Convertible Preferred Stock | |
| Nuwellis Inc | John L. Erb | Director, CEO and President, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Jun 2025 | 100 | 100 | - | - | Series F-1 Convertible Preferred Stock | |
| Nuwellis Inc | John L. Erb | Director, CEO and President, Ten Percent Owner | 09 Jun 2025 | 66 | 34 | - | - | Series F-1 Convertible Preferred Stock | ||
| Miromatrix Medical Inc | John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 54,201 | 110,461 | - | 0 | Common Stock | |
| Nuwellis Inc | John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 2,146 | 2,146 | - | - | Nonstatutory Stock Option (right to buy) | |
| Miromatrix Medical Inc | John L. Erb | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Mar 2023 | 31,250 | 56,260 | - | 1.6 | 50,000 | Common Stock |
| Miromatrix Medical Inc | John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 12,788 | 25,010 | - | 0 | Common Stock | |
| Nuwellis Inc | John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,806 | 15,806 | - | - | Nonstatutory Stock Option (right to buy) | |
| Nuwellis Inc | John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2021 | 8,752 | 8,752 | - | - | Nonstatutory Stock Option (right to buy) | |
| Nuwellis Inc | John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 75,973 | 75,973 | - | - | Incentive Stock Option (right to buy) | |
| Nuwellis Inc | John L. Erb | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 33,125 | 33,125 | - | - | Incentive Stock Option |